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Enterohemorrhagic E.coli (EHEC) is an important foodborne pathogen in the developed
world and can cause life-threatening disease particularly in children. EHEC persists in
the human gut by adhering intimately to colonic epithelium and forming characteristic
attaching/effacing lesions. In this study, we investigated the innate immune response
to EHEC infection with particular focus on antimicrobial peptide and protein expression
by colonic epithelium. Using a novel human colonic biopsy model and polarized T84
colon carcinoma cells, we found that EHEC infection induced expression of human
β-defensin 2 (hBD2), whereas hBD1, hBD3, LL-37, and lysozyme remained unchanged.
Infection with specific EHEC deletion mutants demonstrated that this was dependent on
flagellin, and apical exposure to purified flagellin was sufficient to stimulate hBD2 and also
interleukin (IL)-8 expression ex vivo and in vitro. Flagellin-mediated hBD2 induction was
significantly reduced by inhibitors of NF-κB, MAP kinase p38 and JNK but not ERK1/2.
Interestingly, IL-8 secretion by polarized T84 cells was vectorial depending on the side
of stimulation, and apical exposure to EHEC or flagellin resulted in apical IL-8 release.
Our results demonstrate that EHEC only induces a modest immune response in human
colonic epithelium characterized by flagellin-dependent induction of hBD2 and low levels
of IL-8.
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INTRODUCTION
Enterohemorrhagic E. coli (EHEC) is a foodborne pathogen of worldwide importance (Croxen
et al., 2013). Although infections with EHEC are rare compared with Campylobacter and
Salmonella, they can lead to severe systemic hemolytic uremic syndrome (HUS) resulting in kidney
failure and death (Tarr et al., 2005). EHEC mainly affects young children and the elderly, and the
predominant serotype in most parts of the world is O157:H7 (Croxen and Finlay, 2010).
EHEC causes diarrhea by adhering to human intestinal epithelium, particularly the colon,
and forming attaching and effacing (A/E) lesions (Golan et al., 2011; Lewis et al., 2015).
These are characterized by intimate bacterial attachment to the host cell membrane and
effacement of underlying microvilli. A/E lesion formation is dependent on a bacterial
type III secretion system (T3SS) which enables EHEC to inject effector proteins into
the host cell (Jarvis and Kaper, 1996). Around 50 EHEC effector proteins have been
identified so far (Tobe et al., 2006), affecting many different host cell functions such as
maintenance of epithelial barrier integrity, water and ion transport, and immune response
to infection (Viswanathan et al., 2009). In addition to the T3SS, EHEC also produces Shiga
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toxins (Stxs) which are linked to HUS and strongly cytotoxic
to kidney cells (Obrig and Karpman, 2012). After release into
the gut lumen, Stxs transverse the intestinal epithelium and are
transported to the kidneys via the bloodstream (Schüller, 2011).
EHEC infection in the human gut is accompanied by
neutrophil recruitment to the intestinal mucosa (Griffin et al.,
1990; Kelly et al., 1990), and high levels of the neutrophil
chemoattractant interleukin (IL)-8 have been detected in HUS
patients (Fitzpatrick et al., 1992; Murata et al., 1998) indicating a
key role of this cytokine in the innate immune response to EHEC
infection. In addition to cytokine production which recruits
phagocytes to the site of infection, secretion of antimicrobial
peptides and proteins (AMPs) such as defensins, cathelicidins,
and lysozyme by intestinal epithelium constitutes an important
part in the innate immune defense against intestinal pathogens.
Pore-forming AMPs directly kill bacteria and also promote an
inflammatory immune response by acting as chemoattractants
(Wassing et al., 2014). Human colonic epithelium, the primary
target site of EHEC, produces lysozyme and LL-37, which is
the only cathelicidin in humans and expressed by upper crypt
epithelial cells. In addition, four types of defensins are secreted
by human colonic epithelium: While human β-defensin (hBD)1
is constitutively expressed, hBD2-4 are induced by infection and
inflammation (Eckmann and Kagnoff, 2005; Muniz et al., 2012).
Previous studies have demonstrated that infection with
intestinal pathogens can modulate expression of AMPs and
cytokines by the host epithelium, thereby resulting in an induced
or suppressed immune response (Islam et al., 2001; Zilbauer et al.,
2005; Sharma et al., 2006; Sperandio et al., 2008). In this study, we
have investigated the influence of EHEC infection on AMP and
IL-8 expression in physiologically relevant colonic biopsy and
polarized cell culture models.
MATERIALS AND METHODS
Bacterial Strains and Flagellin
Bacterial strains used in this study are listed in Table 1.
Bacteria were grown standing in LB broth overnight at 37◦C.
Deletion mutants were selected with kanamycin (50µg/ml) or
chloramphenicol (30µg/ml). Bacteria were spun down before
TABLE 1 | E. coli strains used in this study.
Name Description Source or references
EDL933 Wild-type EHEC O157:H7 Riley et al., 1983
EDL933 1escN EDL933 escN deletion mutant Jarvis and Kaper, 1996
EDL933 1fliC EDL933 fliC deletion mutant Gobert et al., 2008
EDL933 1stx EDL933 stx1 stx2 deletion mutant Gobert et al., 2007
85–170 Stx-negative EHEC O157:H7 Tzipori et al., 1987
85–170 1hcpA 85–170 hcpA deletion mutant Xicohtencatl-Cortes
et al., 2007
85–170 1lpfA1 85–170 lpfA1 deletion mutant Fitzhenry et al., 2006
Walla-1 EHEC O157:H7 Ostroff et al., 1990
H0-7184-0336 EHEC O157:H7 G. Smith, Public Health
England
infection and suspended in serum-free culture medium. LPS-free
purified H7 monomeric flagellin was kindly provided by David
Gally, Roslin Institute, Edinburgh.
Cell Culture and Infection
Human colon carcinoma T84 cells (ATCC CCL-248) were
cultured in DMEM/F-12 mixture supplemented with 10% fetal
bovine serum (Sigma) and used between passage 45 and 65. To
obtain polarized monolayers, cells were seeded out on collagen-
coated Transwell filter inserts (12mm diameter, 0.4µm pore;
Corning Costar) at a density of 5×105 cells/insert. Transepithelial
electrical resistance (TER) was monitored using an EVOM2
resistance meter with an STX2 electrode (World Precision
Instruments), and values above 1500  × cm2 after 7–10 d
of differentiation indicated establishment of epithelial barrier
function. Polarized T84 cells were infected with approximately
6 × 107 bacteria in plain DMEM/F-12 medium and incubated
for 3 h. After that, medium was exchanged every hour to
prevent bacterial overgrowth and acidification of the medium.
For 24 h infections, gentamicin (200µg/ml, Sigma) was added 1 h
after infection to slow down bacterial growth, and incubations
were continued without medium exchange for up to 24 h.
For incubations with flagellin and IL-1β (Sigma), no medium
exchange was performed. For signal transduction studies, cells
were incubated with the chemical inhibitors quinazoline (NF-κB)
(28µM, Sigma), SB203580 (p38), SP600125 (JNK), or PD98059
(ERK 1/2) (25µM, Merck Millipore) for 1 h before flagellin
(0.1µg/ml) was added for 6 h. Cells were incubated at 37◦C
in a 5% CO2 atmosphere. At the end of the experiment, cells
were washed twice in PBS to remove non-adherent bacteria and
processed according to further analysis.
Polarized In vitro Organ Culture (pIVOC)
This study was performed with approval from the University
of East Anglia Faculty of Medicine and Health Ethics
Committee (ref 2010/11-030). All samples were provided
through the Norwich Biorepository, which has NRES approval
(ref 08/h0304/85+5). Up to four biopsy samples from the
transverse colon were obtained with informed consent during
colonoscopy of 23 adult patients (24–77 years old) during routine
investigation of potential intestinal disorders. Samples were taken
frommacroscopically normal areas, transported to the laboratory
in IVOC medium and processed within the next hour. Polarized
IVOC was performed as described previously (Schüller et al.,
2009). Briefly, biopsies were mounted mucosal side upwards on
a circular cellulose nitrate filter and sandwiched between two
Perspex disks with a 2mm central aperture (manufactured by the
School of Environmental Sciences workshop, University of East
Anglia). To prevent bacterial leakage, the apical disk was sealed to
the mucosal side of the biopsy with Histoacryl tissue glue (Braun
Medical). The sandwich holding the biopsy was then mounted in
a Snapwell support (Corning Costar) and inserted in a six-well
culture plate. Apical and basal compartments were filled with
IVOC medium, and 20µl of bacterial overnight culture (∼107
bacteria), purified monomeric H7 flagellin or IL-1β were added
apically. A specimen inoculated with medium only was included
with each experiment to exclude in vivo bacterial colonization.
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Samples were incubated in a 5% CO2 atmosphere at 37
◦C on a
rocking platform for 7 h. Bacterial leakage into the basolateral
compartment was assessed by bacterial growth and turbidity
of the medium, and respective samples were excluded from
analysis. At the end of the experiment, biopsies were removed
from the Snapwell support, washed in PBS to remove mucus and
non-adherent bacteria and processed for further analysis.
RNA Isolation and Quantitative Real-Time
PCR (qPCR) Analysis
Total RNA from cells and biopsies was isolated using the
RNeasy Mini kit with on-column DNase digestion (Qiagen)
according to the manufacturer’s instructions. Biopsy tissue was
homogenized with a pestle (Kimble Chase) before extraction.
RNA quality was assessed by gel electrophoresis and OD260/280
determination. RNA was quantified using a Nanodrop ND-
1000 spectrophotometer, and 1µg RNA was converted to cDNA
using the qScript cDNA supermix (Quanta Biosciences) in
a 20µl reaction. Quantitative real-time PCR was performed
using an ABI 7500 PCR system (Applied Biosystems). Primers
were purchased from Sigma-Genosys. Gene-specific sequences
(Table 2) were obtained from published studies or designed
using PrimerBLAST software (http://www.ncbi.nlm.nih.gov/
tools/primer-blast/). Up to 4µl cDNA were amplified in a 10µl
reaction containing 0.5µM of each primer and 5µl of 2× SYBR
Green JumpStart Taq ReadyMix (Sigma). Cycling parameters
were as follows: 2min at 95◦C (initial denaturation); 30 s at
95◦C, 30 s at 60◦C, 35 s at 72◦C (40 cycles); 5min at 72◦C
(final elongation); 15 s at 95◦C, 60 s at 60◦C, 15 s at 95◦C, 15 s
at 60◦C (dissociation for melt curve analysis). PCR product
specificity was confirmed by melt curve analysis and agarose gel
TABLE 2 | Primer sequences used in this study.
Target Primer sequence References
hBD1 F 5′-CTGCTGTTTACTCTCTGCTTACTTTT-3′ Fahlgren et al., 2003
R 5′-CCTCCACTGCTGACGCA-3′
hBD2 F 5′-CTCGTTCCTCTTCATATTCCTGA-3′ Fahlgren et al., 2003
R 5′-CTAGGGCAAAAGACTGGATGAC-3′
hBD3 F 5′-TGAAGCCTAGCAGCTATGAGGATC-3′ Fahlgren et al., 2004
R 5′-CCGCCTCTGACTCTGCAATAA-3′
hBD4 F 5′-CCCAGCATTATGCAGAGACTT-3′ Fahlgren et al., 2004
R 5′-ACCACATATTCTGTCCAATTCAAAT-3′
IL-8 F 5′-TTGAGAGTGGACCACACTGC-3′ Ou et al., 2009
R 5′-TGCACCCAGTTTTCCTTGG-3′
GAPDH F 5′-AGGTCGGAGTCAACGGATTT-3′ Schüller et al., 2009
R 5′-TGGAAGATGGTGATGGGATTT-3′
LL-37 F 5′-GTGCCCCAGGACGACACAGC-3′ This study
R 5′-CCCCTGGCCTGGTTGAGGGT-3′
Lysozyme F 5′-AAAACCCCAGGAGCAGTTAAT-3′ Fahlgren et al., 2003
R 5′-CAACCCTCTTTGCACAAGCT-3′
POLR2A F 5′-GATGGGCAAAAGAGTGGACTT-3′ Schüller et al., 2009
R 5′-GGGTACTGACTGTTCCCCCT-3′
Forward (F) and reverse (R) primer sequences.
electrophoresis. Relative quantification of gene expression was
performed using the comparative Ct method. Ct values for genes
of interest were normalized using the geometric mean Ct of two
housekeeper genes, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and RNA polymerase II polypeptide A (POLR2A).
Fold expression levels in treated samples were calculated relative
to matched non-treated controls using the formula 2−11Ct.
Scanning Electron Microscopy
Samples were fixed with 2.5% glutaraldehyde in PBS and
dehydrated through graded acetone series. Specimens were
dried using tetramethylsilane (Sigma), mounted on aluminum
stubs, sputter-coated with gold (Polaron SC7640 sputter coater,
Quorum Technologies), and viewed with a JEOL JSM 4900 LV
scanning electron microscope.
Immunofluorescence Staining
Biopsy samples were fixed in 3.7% formaldehyde in PBS for
30min, cryoprotected in 15 and 30% sucrose in PBS for 10min,
embedded in OCT compound (Sakura), snap-frozen in a dry
ice/ethanol bath and stored at −70◦C until use. Serial sections
of 7µm were cut with a Microm HM550 cryostat (Thermo
Scientific), picked up on poly L-lysine-coated slides and air-
dried. Tissue sections were blocked with 0.5% BSA in PBS for
20min. Cryosections were subsequently incubated in rabbit anti-
hBD2 (abcam) overnight at 4◦C, washed and incubated in Alexa
Fluor 488-conjugated secondary antibody (Life Technologies)
for 30min. Cell nuclei were counterstained with DAPI (Roche).
FIGURE 1 | EHEC infection induces hBD2 and IL-8 expression in
polarized T84 cells. Polarized T84 cells were apically infected with EHEC
strains EDL933, Walla-1, H07184, or left non-infected (NI) for 9 h. (A) EHEC
infection did not compromise epithelial barrier function. TER after infection is
expressed as percentage of TER before infection. (B) AMP and IL-8 mRNA
levels were quantified by qPCR and expressed as fold changes relative to NI
controls. Data are shown as means ± standard errors of the means (SEM) of
four independent experiments performed in duplicate. *P < 0.05, **P < 0.01,
***P < 0.001 vs. NI control.
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FIGURE 2 | EHEC induction of hBD2 and IL-8 in a polarized human colonic biopsy model. Human colonic biopsy samples were sandwiched between two
Perspex disks with a central aperture and mounted in Snapwell supports as described in Experimental Procedures. Mucosal sides of matched biopsies were infected
with EHEC strains EDL933, Walla-1, H07184, or left NI for 7 h. (A) Scanning electron micrograph of colonic biopsy after 7 h of incubation. The white circle indicates
the central aperture of the disk. Bar = 200µm. (B) Intact colonic surface epithelium at higher magnification. Bar = 50µm. (C) EDL933 intimately adhering to colonic
biopsy epithelium. Bar = 2µm. Images are representative of three experiments performed in duplicate. (D) AMP and IL-8 mRNA levels were quantified by qPCR and
expressed as fold changes relative to matched NI controls. Data points represent individual biopsies from a total of six patients. Medians are indicated by a line.
*P < 0.05, **P < 0.01 vs. NI control.
Samples were mounted in Vectashield (Vector Laboratories) and
analyzed using a fluorescence light microscope (Axiovert 200 M,
Zeiss).
IL-8 ELISA
Polarized T84 cells were lysed on ice in 1% Triton X-100
and 1µl/200µl protease inhibitor cocktail (Sigma) in PBS, and
Triton-insoluble proteins were removed by centrifugation. IL-8
concentrations in lysates and supernatants were determined
using a human IL-8 ELISA kit (PeproTech) according to the
manufacturer’s instructions.
Statistics
Statistical analysis was performed using GraphPad Prism
software (version 5). qPCR data were log transformed before
analysis. For parametric T84 cell data, one-way ANOVA with
Tukey’s multiple comparisons test was used to determine
differences between multiple groups. For non-parametric biopsy
data, Wilcoxon’s signed-rank test or Kruskall–Wallis with Dunn’s
multiple comparisons test was used to determine differences
between two or multiple groups, respectively. A P < 0.05 was
considered significant.
RESULTS
Apical EHEC Infection of Polarized T84
Cells Induces hBD2 and IL-8 Expression
To determine the influence of EHEC infection on AMP and
IL-8 expression by human colonic epithelium, polarized T84
human colon carcinoma cells were infected with EHEC O157:H7
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FIGURE 3 | EHEC induction of hBD2 and IL-8 expression in polarized T84 cells is dependent on flagellin. Polarized T84 cells were apically infected with
EHEC EDL933 wild-type (WT) and isogenic deletion mutants in fliC, escN, or stx (A) or EHEC 85–170 wild-type (WT) and isogenic deletion mutants in hcp or lpfA1 (B)
for 9 h. IL-8 and hBD2 mRNA levels were quantified by qPCR and expressed as fold changes relative to NI controls. Data are shown as means ± SEM of three
independent experiments performed in duplicate. ***P < 0.001 vs. NI control.
strains EDL933, Walla-1, and H0-7184-0336 (H07184) on the
apical side. Bacterial overgrowth and loss of epithelial integrity
was prevented by removal of bacteria after 3 h and subsequent
medium exchange at hourly intervals. As shown in Figure 1A,
this protocol resulted in maintenance of epithelial barrier
function for up to 9 h as determined by TER. Expression of
hBD1-4, LL-37, lysozyme, and IL-8 was determined by qPCR
analysis. Results in Figure 1B show that apical EHEC infection
resulted in a significant induction of hBD2 (21.5 ± 9.1 fold for
EDL933, 70.4 ± 21.8 fold for Walla-1, and 31.5 ± 2.0 fold for
H07184) and IL-8 (6.0 ± 1.6 fold for EDL933, 8.3 ± 2.4 fold
for Walla-1, and 8.2 ± 3.9 fold for H07184) mRNA expression
compared with non-infected (NI) controls whereas no significant
change was observed for hBD1, hBD3, LL-37, and lysozyme.
No specific amplification product was detected for hBD4.
Subsequent kinetic analysis of hBD2 and IL-8 mRNA expression
indicated that levels of both transcripts were first significantly
induced at 6 h post-infection and showed a continuous increase
during a 12 h period of infection (Supplementary Figure 1).
For practical reasons, infections of polarized T84 cells were
performed for 9 h in subsequent experiments.
Apical EHEC Infection Results in hBD2 and
IL-8 Induction in a Polarized Human
Colonic Biopsy Model
Our recent studies have demonstrated EHEC adherence to
human colonic biopsy epithelium by forming typical A/E lesions
(Lewis et al., 2015). To investigate the effect of EHEC infection
on AMP and IL-8 expression ex vivo, a pIVOC model, which
restricts bacterial access to the mucosal side of the biopsy, was
developed. This was based on the pIVOC system established
earlier to investigate the inflammatory response in duodenal
biopsies (Schüller et al., 2009). Colonic biopsy samples were
mounted in Snapwell supports, infected with EDL933, Walla-1,
or H07184 on the mucosal side and incubated for up to
7 h. Tissue preservation and EHEC adherence were evaluated
by scanning electron microscopy. As shown in Figure 2A,
good tissue morphology was observed within the area of the
central aperture (white circle) with intact surface epithelium
visible at higher magnifications (Figure 2B). In addition, EHEC
adhered intimately to colonic epithelium as described previously
(Figure 2C; Lewis et al., 2015). Analysis of AMP and IL-8
expression by qPCR demonstrated a significant increase in hBD2
(median fold increase = 8.1 for EDL933 and 5.7 for H07184)
and IL-8 expression (median fold increase = 6.6 for EDL933,
5.2 for Walla-1, and 4.8 for H07184) in EHEC-infected samples
compared with non-infected controls. In contrast, transcript
levels of hBD1, LL-37, and lysozyme were not significantly
affected by EHEC infection (Figure 2D). Amplification levels
for hBD3 and hBD4 were generally below detection threshold
levels. However, amplification products of corresponding sizes
were detected in some experiments, thereby confirming primer
specificity and functionality of the qPCR assay (data not
shown).
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FIGURE 4 | EHEC stimulation of IL-8 and hBD2 expression in colonic
biopsies requires flagellin. Colonic biopsies were infected with EHEC
EDL933 wild-type (WT), isogenic deletion mutants in fliC, escN, or stx or left NI
on the mucosal side, and incubations were performed for 7 h. IL-8 and hBD2
mRNA levels were quantified by qPCR and expressed as fold changes relative
to matched NI controls. Data points represent individual biopsies from a total
of four patients. Medians are indicated by a line. *P < 0.05, **P < 0.01,
***P < 0.001 vs. NI control.
EHEC Induction of Colonic Epithelial hBD2
and IL-8 Expression Is Dependent on
Flagellin
We next determined which EHEC proteins were involved in
hBD2 and IL-8 induction in colonic epithelium. Polarized T84
cells were apically infected with wild-type (wt) EDL933 or
isogenic deletion mutants in fliC (flagellin, main component
of EHEC flagellum), escN (cytoplasmic ATPase of T3SS),
or stx (Stxs) for 9 h. In addition, the contribution of long
polar fimbriae (Lpf) and hemorrhagic coli pili (HCP) was
examined by using isogenic deletion mutants in lpfA1 and
hcp of EHEC strain 85–170. None of the strains significantly
compromised epithelial barrier function as determined by TER
(Supplementary Figure 2A). Expression levels of hBD2 and IL-8
were determined by qPCR. Whereas, infection with EDL933 wt,
1escN, and1stx showed a significant induction of hBD2 (48.6±
12.3 fold for wt, 60.5± 15.6 fold for1escN, and 41.5± 8.3 fold for
1stx) and IL-8 (5.6± 1.3 fold for wt, 7.5± 1.2 fold for1escN, and
4.9 ± 0.3 fold for1stx) expression vs. NI controls, no significant
effect was observed in EDL933 1fliC-infected cells (Figure 3A).
For infections with 85–170, all strains significantly increased
expression of hBD2 (195.9 ± 50.1 fold for wt, 168.6 ± 40.4 fold
for 1hcp, and 163.4 ± 26.8 fold for 1lpfA1) and IL-8 (84.3 ±
21.8 fold for wt, 157.5 ± 45.7 fold for 1hcp, and 88.4 ± 28.0
FIGURE 5 | EHEC flagellin is sufficient to induce hBD2 and IL-8
expression in polarized T84 cells. Polarized T84 cells were incubated with
EDL933, purified flagellin or left NI on the apical side. IL-8 and hBD2 mRNA
levels were quantified by qPCR and expressed as fold changes relative to NI
controls. (A) Purified flagellin induced a dose-dependent increase in hBD2
mRNA expression after 9 h. Data are shown as means ± SEM of three
independent experiments performed in duplicate. (B) Kinetics of IL-8 and
hBD2 induction by purified flagellin (0.1µg/ml). Data are shown as means ±
SEM of two independent experiments performed in duplicate. (C) Purified
flagellin induced a dose-dependent increase in IL-8 mRNA expression after
2 h. Data are shown as means ± SEM of two independent experiments
performed in duplicate. *P < 0.05, **P < 0.01, ***P < 0.001 vs. NI control.
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FIGURE 6 | EHEC flagellin induces hBD2 and IL-8 expression in colonic
biopsies. Colonic biopsies were incubated with purified flagellin (1µg/ml) or
left NI on the mucosal side for 7 h. IL-8 and hBD2 mRNA levels were quantified
by qPCR and expressed as fold changes relative to matched NI controls. Data
points represent individual biopsies from a total of four patients. Medians are
indicated by a line. *P < 0.05, **P < 0.01 vs. NI control.
fold for 1lpfA1) vs. NI controls (Figure 3B). Notably, induction
levels of hBD2 and IL-8 expression by EHEC strain 85–170 were
considerably higher compared with EDL933 (Figure 3).
We also determined the effect of flagellin, T3S and Stxs on
hBD2 and IL-8 expression in colonic pIVOC. As shown in
Figure 4, EDL933 wt, 1escN, and 1stx significantly enhanced
hBD2 (median fold increase = 15.9 for wt, 14.3 for 1escN, and
17.8 for1stx) and IL-8 (median fold increase= 3.6 for wt, 3.1 for
1escN, and 4.9 for 1stx) expression in colonic biopsies whereas
no significant effect was observed for the1fliCmutant.
Purified Flagellin Induces hBD2 and IL-8
Expression in Colonic Epithelium
To examine whether EHEC flagellin alone was sufficient to
increase hBD2 and IL-8 expression, polarized T84 cells were
infected with EDL933 or incubated with different concentrations
of purified LPS-free monomeric H7 flagellin on the apical
side for 9 h. No significant effect on TER was observed under
any of the conditions tested (Supplementary Figure 2A). As
demonstrated in Figure 5A, a dose-dependent increase in hBD2
mRNA expression was observed after 9 h of incubation with
similar induction levels for 1µg/ml flagellin and infection with
EDL933 (101.5 ± 24.0 fold for flagellin and 99.0 ± 23.0 fold
for EDL933). In contrast, only very low induction levels were
noted for IL-8 (Figure 5B, data shown for 0.1µg/ml flagellin).
Therefore, kinetic analyses were performed, and cells were
apically exposed to flagellin for 1–9 h.Whereas, highest induction
levels for hBD2 were observed after 6–9 h of flagellin exposure,
IL-8 mRNA expression was induced much earlier and peaked at
1–3 h of exposure (Figure 5B). IL-8 induction was subsequently
examined after 2 h of flagellin exposure, and a dose-dependent
response was noted with induction levels for 1µg/ml flagellin
approximating those observed during infection with EDL933
(62.6 ± 8.9 fold for flagellin and 80.8 ± 10.5 fold for EDL933;
Figure 5C).
Similar to findings in polarized T84 cells, purified flagellin was
also sufficient to induce hBD2 (median fold increase = 5.3) and
FIGURE 7 | Flagellin-mediated hBD2 induction is dependent on NF-κB,
MAPK p38, and JNK. Polarized T84 cells were incubated with specific
inhibitors of NF-κB, p38, JNK, ERK1/2, or solvent (control) for 1 h before
purified flagellin (0.1µg/ml) was added for 6 h. Alternatively, T84 cells were left
untreated (NT) for 7 h. (A) Influence of chemical inhibitors on epithelial barrier
function. TER after treatment is expressed as percentage of TER before
treatment. (B) hBD2 and IL-8 mRNA levels were quantified by qPCR and
expressed as fold changes relative to NT samples. ***P < 0.001 vs. control.
Data are shown as means ± SEM of three independent experiments
performed in duplicate.
IL-8 (median fold increase = 2.2) expression in colonic pIVOC
(Figure 6).
Flagellin-Induced hBD2 Expression Is
Mediated by NF-κB, Map Kinases p38 and
JNK
We further characterized the signaling pathways involved
in flagellin-induced hBD2 and IL-8 expression. To this aim,
polarized T84 cells were treated with specific chemical inhibitors
before flagellin (0.1µg/ml) was added. Gene expression
was quantified by qPCR. None of the chemical inhibitors
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FIGURE 8 | EHEC stimulates hBD2 peptide expression in colonic
biopsy epithelium. Colonic biopsies were incubated with EDL933, purified
flagellin (1µg/ml) or left NI for 8 h. Cryosections from snap-frozen tissue were
stained with anti-hBD2 (green), and cell nuclei were counterstained with DAPI
(blue). Arrowheads show epithelial cells with induced hBD2 expression.
Images are displayed as separate monochrome images of each fluorescence
channel (hBD2, DAPI) and merged color images from both channels (merge).
Shown are representative images from two independent experiments
performed in duplicate. Bars = 10µm.
compromised epithelial barrier function (Figure 7A). While
inhibition of NF-κB or the MAPKs p38 and JNK significantly
reduced hBD2 gene expression, treatment with the ERK1/2
inhibitor did not have any significant effect (Figure 7B). For
IL-8, all inhibitors reduced gene expression, but this did not
reach significance (Figure 7B).
EHEC Infection Induces Epithelial hBD2
Peptide Expression in Colonic Biopsies
Having shown that EHEC flagellin induced hBD2 mRNA
expression, we investigated whether this also affected
hBD2 peptide levels. Colonic biopsies were infected with
EDL933 or incubated with purified flagellin (1µg/ml) on the
mucosal side, and hBD-2 peptide expression was assessed by
immunofluorescence staining. As shown in Figure 8, elevated
hBD2 peptide expression was observed in epithelial cells of
colonic biopsies incubated with EDL933 or flagellin vs. NI
controls.
EHEC-Induced IL-8 Protein Secretion in
Polarized T84 Cells Is Directional and
Depends on the Side of Exposure
We further investigated EHEC-induced IL-8 expression at the
protein level. Polarized T84 cells were apically infected with
EDL933 or incubated with the potent IL-8 inducer IL-1β
(10 ng/ml) for 24 h. This time point was chosen according to
previous IL-8 secretion studies on EHEC and enteropathogenic
E. coli (EPEC) (Hauf and Chakraborty, 2003; Baruch et al., 2011;
Sham et al., 2011). To prevent cell damage and breach of barrier
function due to bacterial overgrowth and acidification, EHEC-
infected monolayers were treated with gentamicin (200µg/ml)
after 1 h. This treatment did not result in complete killing, but
reduced bacterial growth so that infections could be continued
for up to 24 h. TER was not significantly affected by any of the
treatments (Supplementary Figure 2B) indicating maintenance
of epithelial barrier function. At the end of the incubation, IL-
8 protein levels were determined in cell lysates and apical and
basolateral supernatants. As shown in Figure 9A, apical EHEC
infection significantly increased IL-8 protein levels in apical
supernatants (240.9 ± 27.5 vs. 32.0 ± 6.2 pg/well in NI controls)
and to a lesser extent in cell lysates (88.9 ± 21.5 vs. 16.6 ± 1.4
pg/well in NI controls) but not in basolateral media. Similarly,
apical IL-1β exposure resulted in significantly enhanced amounts
of IL-8 in apical supernatants (102.3 ± 14.9 vs. 32.0 ± 6.2
pg/well in NI controls) but not in cell lysates or basolateral
media. We further extended these studies and investigated the
influence of the side of exposure on the direction of IL-8
release into the media. To this aim, polarized T84 cells were
incubated with EDL933 or purified flagellin (1µg/ml) on the
apical or basolateral side for 24 h, and IL-8 levels were evaluated
in apical and basolateral supernatants. None of the treatments
significantly affected the TER (Supplementary Figure 2B). As
demonstrated in Figure 9B, apical exposure to EDL933 or
flagellin led to a significant increase of IL-8 secretion into
apical supernatants (569.5 ± 46.2 or 761.2 ± 8.5 vs. 108.2 ±
16.9 pg/well in NI controls, respectively) whereas IL-8 levels in
basolateral media were not significantly affected. On the other
hand, basolateral exposure of polarized T84 cells to EDL933
or flagellin significantly stimulated IL-8 protein release into
basolateral compartments (506.6 ± 103.2 or 1119.0 ± 181.4
vs. 128.6 ± 8.1 pg/well in NI controls, respectively) whereas
IL-8 levels in apical media were not significantly affected
(Figure 9B).
DISCUSSION
The intestinal epithelium is the first line of defense against enteric
pathogens, and the expression and release of AMPs represents an
important part of the innate immune response during intestinal
infections. In the colon, the main target site of EHEC, epithelial
cells express hBD1-4, LL-37, and lysozyme. In this study, we have
investigated the effect of EHEC infection on AMP expression
in two physiologically relevant infection models: human colonic
biopsies and polarized T84 cells. As demonstrated by our recent
studies, IVOC of human colonic biopsies supports EHEC A/E
lesion formation (Lewis et al., 2015). However, standard IVOC
is not suitable to study the host immune response as it allows
bacterial access and stimulation of the submucosal tissue surface.
Therefore, we adopted a polarized IVOC method developed
previously for small intestinal biopsy samples (Schüller et al.,
2009). In addition to IVOC, we used T84 human colon carcinoma
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FIGURE 9 | EHEC-induced IL-8 release from polarized T84 cells is
directional and depends on the side of exposure. Polarized T84 cells
were incubated with EDL933, IL-1β (10 ng/ml), flagellin (1µg/ml), or left NI on
the apical (A,B) or basolateral side (B) for 24 h. IL-8 protein levels in cell
lysates, apical and basolateral supernatants were determined by ELISA. (A)
Apical exposure to EDL933 or IL-1β stimulated apical IL-8 release. Data are
shown as means ± SEM of three independent experiments performed in
duplicate. (B) Apical (AP) exposure to EDL933 or flagellin induced apical IL-8
release (white columns), whereas basolateral (BL) exposure to EDL933 or
flagellin induced basolateral IL-8 release (black columns). Data are shown as
means ± SEM of two independent experiments performed in triplicate.
**P < 0.01, ***P < 0.001 vs. NI control.
cells which lack expression of the Stx receptor Gb3 similar to
human colonic epithelium (Schüller et al., 2004) and form highly
polarized epithelia with high TER when grown on membrane
supports (Madara et al., 1987).
Our results show that apical EHEC infection induced hBD2
expression in both colonic biopsies and polarized T84 cells
whereas all other AMPs remained unaffected. This is of relevance
as hBD2 has been demonstrated to directly kill E. coli and also
promote the release of immuno-modulating adenosine (Estrela
et al., 2013). In contrast to hBD1which is constitutively expressed
in human colonic epithelium and thus confers a baseline
protection against bacterial pathogens, hBD2 is undetectable
or only expressed at very low levels in healthy children and
adults, but elevated in patients with inflammatory bowel disease
(Fahlgren et al., 2003; Zilbauer et al., 2010). This might be
due to enhanced contact of the gut microbiota with intestinal
epithelium, and previous studies have demonstrated induction
of hBD2 by both commensal and pathogenic bacteria. Most of
these studies were performed using intestinal epithelial cell lines
(e.g., Caco-2 and HT-29) and have demonstrated stimulation of
hBD2 expression by enteroinvasive pathogens such as Salmonella
spp., Shigella flexneri and dysenteriae, enteroinvasive E. coli, and
Campylobacter jejuni (O’Neil et al., 1999; Ogushi et al., 2001;
Hase et al., 2002; Zilbauer et al., 2005). In addition, non-invasive
EPEC and probiotic E. coli Nissle 1917 have also been shown to
induce hBD2 expression (Schlee et al., 2007; Khan et al., 2008).
In contrast, very few studies have been carried out on human
intestinal tissue so far. Whereas experiments using human
intestinal xenografts in mice have confirmed hBD2 induction by
Salmonella typhi (O’Neil et al., 1999), no change in expression
was observed after infection with S. flexneri (Sperandio et al.,
2008). To the best of our knowledge, this is the first study
using IVOC of human intestinal biopsies to investigate the AMP
response to bacterial infection.
We further investigated the bacterial factors involved in hBD2
induction and found that EHEC flagellin was both necessary
and sufficient to stimulate a response ex vivo and in vitro. This
is in agreement with studies on EPEC and Salmonella enterica
serotype Enteritidis which also demonstrated hBD2 induction
mediated by flagellin (Ogushi et al., 2001; Schlee et al., 2007;
Khan et al., 2008). Interestingly, the hBD2 response to flagellin
from non-pathogenic E. coli such as ATCC 259922, JM109, and
Nissle 1917 is strain-dependent suggesting differences in binding
to a potential receptor (Schlee et al., 2007). We further tested
which signal transduction pathways were involved in flagellin-
mediated hBD2 induction by using chemical inhibitors of NF-κB
and MAPKs. These studies showed that flagellin-induced hBD2
expression was dependent on NF-κB, MAPK p38, and JNK but
not ERK1/2. NF-κB dependency of hBD2 induction has been
described before in LPS-stimulated macrophages (Tsutsumi-Ishii
and Nagaoka, 2002) and intestinal epithelial cells treated with
flagellin from E. coli Nissle (Wehkamp et al., 2004). The latter
study also demonstrated involvement of the MAPKs JNK but
not p38 or ERK 1/2. In addition, Bacteroides fragilis enterotoxin
induced hBD2 by p38 activation (Yoon et al., 2010), and
inhibitors of p38, JNK and ERK 1/2 reduced hBD2 induction
by probiotic lactobacilli, although this did not reach significance
(Schlee et al., 2008).
In addition to studying the AMP response to EHEC infection,
we also examined expression of the pro-inflammatory cytokine
IL-8 which acts as a chemoattractant and recruits neutrophils
to the site of infection (Baggiolini and Clark-Lewis, 1992).
Previous studies using non-polarized cells have shown that EHEC
infection induces IL-8 release, and that this is dependent on
NF-κB and MAP kinases (Dahan et al., 2002; Gobert et al., 2007).
While several bacterial factors including long polar fimbriae,
hemorrhagic coli pili, and Shiga toxins (Thorpe et al., 2001;
Ledesma et al., 2010; Farfan et al., 2013) have been implicated in
this response, many studies suggest that flagellin is the principal
inducer of IL-8 production during EHEC infection (Berin et al.,
2002; Zhou et al., 2003; Miyamoto et al., 2006). This is confirmed
by our results on human colonic biopsies and polarized T84
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 June 2016 | Volume 6 | Article 68
Lewis et al. β-Defensin 2 Induction in EHEC Infection
cells and agrees with earlier ex vivo studies using human colonic
xenografts in mice (Miyamoto et al., 2006).
While flagellin provides the initial stimulus for a pro-
inflammatory response, it has been shown that T3S effectors
encoded outside the locus of enterocyte effacement dampen
down NF-κB activation and IL-8 release at later stages of EHEC
and EPEC infection (Hauf and Chakraborty, 2003; Nadler et al.,
2010; Baruch et al., 2011). In addition, a similar T3S-dependent
suppressive effect has been observed in EPEC-dependent hBD2
expression (Khan et al., 2008). Notably, all of these studies have
been performed using cervical HeLa cells or undifferentiated
Caco-2 cells. Interestingly, we did not detect any significant
inhibitory effect of the T3SS on hBD2 and IL-8 expression
during EHEC infection of colonic biopsies and polarized T84
cells. A similar observation has been reported by Ruchaud-
Sparagano and colleagues who demonstrated T3S-dependent
suppression of IL-8 induction in EPEC-infected polarized Caco-
2 but not T84 cells (Ruchaud-Sparagano et al., 2007). As fully
differentiated Caco-2 cells display a small intestinal rather than
colonic phenotype (Engle et al., 1998), these results might suggest
a delayed or absent immunosuppressive effect of EHEC infection
in human colonic vs. small intestinal epithelium.
As it was technically not feasible to accurately quantify
epithelial IL-8 secretion in colonic biopsies due to the presence
and varying thickness of the submucosal tissue, polarized T84
cells were employed for this part of the study. Unexpectedly,
we found that IL-8 secretion was vectorial and depended on the
direction of the stimulus: Whereas, apical exposure to EHEC
or flagellin induced apical IL-8 release, basolateral exposure
resulted in IL-8 secretion to the basolateral side. Whilst EHEC-
induced IL-8 secretion has not been examined in polarized
T84 cells, studies on EPEC and EPEC flagellin have reported
increased basolateral IL-8 secretion after basolateral but not
apical stimulation (Zhou et al., 2003; Ruchaud-Sparagano et al.,
2007). Very few studies have examined apical IL-8 secretion as it
is generally assumed that IL-8 is mainly secreted basolaterally to
mediate neutrophil recruitment to the epithelium. In line with
this theory, predominantly basolateral IL-8 secretion has been
shown in polarized HCA-7 cells stimulated with EHEC flagellin
and polarized Caco-2 cells apically exposed to EPEC (Berin et al.,
2002; Ruchaud-Sparagano et al., 2007). However, similar to our
results, stimulation of polarized HT 29/19A or Caco-2 cells with
IL-1 or TNF-α resulted in polarized IL-8 secretion dependent on
the side of exposure (Lammers et al., 1994; Sonnier et al., 2010).
In addition, vectorial IL-8 release has been shown in flagellin-
stimulated polarized Caco-2 cells (Rossi et al., 2013). While
luminal IL-8 could aid neutrophil transmigration across the
epithelium as demonstrated in urinary tract infections (Godaly
et al., 2001), autocrine epithelial signaling via apically expressed
IL-8 receptors (CXCR1) has also been suggested (Rossi et al.,
2013).
Taken together, our study demonstrates that colonic EHEC
infection elicits a weak innate immune response with induction
of hBD2 but no other AMPs and low levels of IL-8. These results
suggest that inflammation plays a minor role in intestinal EHEC
pathogenesis.
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Supplementary Figure 1 | Kinetics of hBD2 and IL-8 gene expression
during EHEC infection. Polarized T84 cells were apically infected with EHEC
strain EDL933 for 3–12 h, or left NI for 12 h. hBD2 and IL-8 mRNA levels were
quantified by qPCR and expressed as fold changes relative to NI controls. Data
represent means ± SEM of two independent experiments. *P < 0.05, **P < 0.01,
***P < 0.001 vs. NI control.
Supplementary Figure 2 | Influence of different treatments on T84 cell
barrier function. Polarized T84 cells were apically inoculated with EHEC
wild-type EDL933 or 85–170 (WT), deletion mutants (1fliC, escN, stx, hcp, or
lpfA1), purified flagellin (1µg/ml) or left non-infected (NI) for 9 h (A) or incubated
with EDL933, IL-1β (10 ng/ml), flagellin (1µg/ml), or left NI on the apical (AP) or
basolateral side (BL) for 24 h (B). TER after treatment is expressed as percentage
of TER before treatment. Data are shown as means ± SEM of three independent
experiments performed in duplicate.
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